188 related articles for article (PubMed ID: 17616674)
1. Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling.
Schrecengost RS; Riggins RB; Thomas KS; Guerrero MS; Bouton AH
Cancer Res; 2007 Jul; 67(13):6174-82. PubMed ID: 17616674
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer antiestrogen resistance 3-p130
Cross AM; Wilson AL; Guerrero MS; Thomas KS; Bachir AI; Kubow KE; Horwitz AR; Bouton AH
Oncogene; 2016 Nov; 35(45):5850-5859. PubMed ID: 27109104
[TBL] [Abstract][Full Text] [Related]
3. Association of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistance.
Wallez Y; Riedl SJ; Pasquale EB
J Biol Chem; 2014 Apr; 289(15):10431-10444. PubMed ID: 24584939
[TBL] [Abstract][Full Text] [Related]
4. Regulation of p130(Cas)/BCAR1 expression in tamoxifen-sensitive and tamoxifen-resistant breast cancer cells by EGR1 and NAB2.
Kumbrink J; Kirsch KH
Neoplasia; 2012 Feb; 14(2):108-20. PubMed ID: 22431919
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer anti-estrogen resistance 3 (BCAR3) protein augments binding of the c-Src SH3 domain to Crk-associated substrate (p130cas).
Makkinje A; Vanden Borre P; Near RI; Patel PS; Lerner A
J Biol Chem; 2012 Aug; 287(33):27703-14. PubMed ID: 22711540
[TBL] [Abstract][Full Text] [Related]
6. AND-34/BCAR3 differs from other NSP homologs in induction of anti-estrogen resistance, cyclin D1 promoter activation and altered breast cancer cell morphology.
Near RI; Zhang Y; Makkinje A; Vanden Borre P; Lerner A
J Cell Physiol; 2007 Sep; 212(3):655-65. PubMed ID: 17427198
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway.
Dorssers LC; van Agthoven T; Brinkman A; Veldscholte J; Smid M; Dechering KJ
Breast Cancer Res; 2005; 7(1):R82-92. PubMed ID: 15642172
[TBL] [Abstract][Full Text] [Related]
8. BCAR1, a human homologue of the adapter protein p130Cas, and antiestrogen resistance in breast cancer cells.
Brinkman A; van der Flier S; Kok EM; Dorssers LC
J Natl Cancer Inst; 2000 Jan; 92(2):112-20. PubMed ID: 10639512
[TBL] [Abstract][Full Text] [Related]
9. BCAR3/AND-34 can signal independent of complex formation with CAS family members or the presence of p130Cas.
Vanden Borre P; Near RI; Makkinje A; Mostoslavsky G; Lerner A
Cell Signal; 2011 Jun; 23(6):1030-40. PubMed ID: 21262352
[TBL] [Abstract][Full Text] [Related]
10. BCAR3 regulates Src/p130 Cas association, Src kinase activity, and breast cancer adhesion signaling.
Schuh NR; Guerrero MS; Schrecengost RS; Bouton AH
J Biol Chem; 2010 Jan; 285(4):2309-17. PubMed ID: 19940159
[TBL] [Abstract][Full Text] [Related]
11. Expression of a phosphorylated p130(Cas) substrate domain attenuates the phosphatidylinositol 3-kinase/Akt survival pathway in tamoxifen resistant breast cancer cells.
Soni S; Lin BT; August A; Nicholson RI; Kirsch KH
J Cell Biochem; 2009 May; 107(2):364-75. PubMed ID: 19330798
[TBL] [Abstract][Full Text] [Related]
12. Identification of Novel Crk-associated Substrate (p130Cas) Variants with Functionally Distinct Focal Adhesion Kinase Binding Activities.
Kumbrink J; Soni S; Laumbacher B; Loesch B; Kirsch KH
J Biol Chem; 2015 May; 290(19):12247-55. PubMed ID: 25805500
[TBL] [Abstract][Full Text] [Related]
13. CrkI and p130(Cas) complex regulates the migration and invasion of prostate cancer cells.
Dai Y; Qi L; Zhang X; Li Y; Chen M; Zu X
Cell Biochem Funct; 2011 Dec; 29(8):625-9. PubMed ID: 22144090
[TBL] [Abstract][Full Text] [Related]
14. Protein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell lines.
van Agthoven T; Godinho MF; Wulfkuhle JD; Petricoin EF; Dorssers LC
Int J Cancer; 2012 Nov; 131(9):1998-2007. PubMed ID: 22328489
[TBL] [Abstract][Full Text] [Related]
15. Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b.
Riggins RB; Thomas KS; Ta HQ; Wen J; Davis RJ; Schuh NR; Donelan SS; Owen KA; Gibson MA; Shupnik MA; Silva CM; Parsons SJ; Clarke R; Bouton AH
Cancer Res; 2006 Jul; 66(14):7007-15. PubMed ID: 16849545
[TBL] [Abstract][Full Text] [Related]
16. A novel association between p130Cas and resistance to the chemotherapeutic drug adriamycin in human breast cancer cells.
Ta HQ; Thomas KS; Schrecengost RS; Bouton AH
Cancer Res; 2008 Nov; 68(21):8796-804. PubMed ID: 18974122
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes.
Guo J; Canaff L; Rajadurai CV; Fils-Aimé N; Tian J; Dai M; Korah J; Villatoro M; Park M; Ali S; Lebrun JJ
Breast Cancer Res; 2014 Dec; 16(6):476. PubMed ID: 25499443
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer antiestrogen resistance 3 (BCAR3) promotes cell motility by regulating actin cytoskeletal and adhesion remodeling in invasive breast cancer cells.
Wilson AL; Schrecengost RS; Guerrero MS; Thomas KS; Bouton AH
PLoS One; 2013; 8(6):e65678. PubMed ID: 23762409
[TBL] [Abstract][Full Text] [Related]
19. Lysyl oxidase regulates actin filament formation through the p130(Cas)/Crk/DOCK180 signaling complex.
Payne SL; Hendrix MJ; Kirschmann DA
J Cell Biochem; 2006 Jul; 98(4):827-37. PubMed ID: 16440329
[TBL] [Abstract][Full Text] [Related]
20. AND-34/BCAR3 regulates adhesion-dependent p130Cas serine phosphorylation and breast cancer cell growth pattern.
Makkinje A; Near RI; Infusini G; Vanden Borre P; Bloom A; Cai D; Costello CE; Lerner A
Cell Signal; 2009 Sep; 21(9):1423-35. PubMed ID: 19454314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
